Publications

5677 Results

Circulating tumor cell (CTC) count is prognostic of overall survival in metastatic hormone sensitive prostate cancer (mHSPC)

Authors
A Goldkorn;C Tangen;M Plets;D Bsteh;T Xu;J Pinski;S Ingles;T Triche;G MacVicar;D Vaena;A Crispino;D McConkey;P Lara;M Hussain;D Quinn;T Dorff;IM Thompson;N Agarwal
Journal / Conference
JAMA Network Open Oct 1;7(10):e2437871
Year
2024
Research Committee(s)
Genitourinary
PMID
PMID39374015
PMC
PMC11581504
Study Number(s)
S1216

SWOG/NCI S1609 Phase II Basket Trial Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART): Non-Epithelial Ovarian Cancer

Authors
Y Chae;M Othus;S Patel;K Wilkinson;E Whitman-Purves;J Lea;J Schallenkamp;N Adra;L Appleman;M Alden;J Thomes Pepin;J Ellerton;A Poklepovic;A Walter;M Rampurwala;W Robinson;L Il-Young Chung;H Kim;C McLeod;G Lopez;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
Clinical Cancer Research Oct 17. doi: 10.1158/1078-0432.CCR-24-0606. Online ahead of print
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39417692
Study Number(s)
S1609

DNA Damage Response Gene Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial

Authors
G Iyer;C Tangen;M Sarfaty;A Regazzi;I Lee;M Fong;W Choi;C Dinney;T Flaig;I Thompson;S Lerner;D McConkey;J Rosenberg
Journal / Conference
JCO Precision Oncology Nov:8:e2400287. doi: 10.1200/PO.24.00287. Epub 2024 Nov 5. 2024
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
S1314

Navigating the Interplay of Cancer, Hemostasis, and Thrombosis: Investigating Tissue Factor in Colorectal Cancer

Authors
S Algaze;Y Yang;J Millstein;F Battaglin;S Soni;P Mittal;K Ashouri;A Wong;P Jayachandran;H Arai;J Lo;W Zhang;L Torres-Gonzalez;H Liebman;H-J Lenz
Journal / Conference
ICTHIC Meeting (May 17-19, 2024, Bergamo, Italy)
Year
2024
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Development and validation of the RSClinN+ tool that integrates the 21-gene recurrence score and clinical variables to predict prognosis and chemotherapy benefit for hormone receptor-positive (HR+), HER2-negative (HER2-), node-positive breast cancer

Authors
L Pusztai;J Hoag;K Albain;W Barlow;S Stemmer;A Meisner;G Hortobagyi;S Shak;J Rae;R Baehner;P Sharma;K Kalinsky
Journal / Conference
Journal of Clinical Oncology Dec 2:JCO2401507. doi: 10.1200/JCO-24-01507. Online ahead of print
Year
2024
Research Committee(s)
Breast
PMID
PMID39621968
Study Number(s)
S1007, SWOG-8814

Long-term side effects and complications after prostate cancer treatment

Authors
J Unger;C Till;C Tangen;D Hershman;P Goodman;M Leblanc;W Barlow;R Vaidya;L Minasian;H Parnes;IM Thompson
Journal / Conference
JAMA Oncology Nov 7;10(12):1654-1662
Year
2024
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID39509091
PMC
PMC11544550
Study Number(s)
S0000, SWOG-9217

Association Between Surgical Margin Distance, Locoregional Recurrence, and Survival Among Patients Undergoing Sublobar Resection in CALGB 140503 (Alliance)

Authors
C Yang;L Martin;X Wang;B Damman;T Stinchcombe;J Mentlick;R Landreneau;D Wigle;D Jones;M Conti;A Ashrafi;M Liberman;M de Perrot;J Mitchell;R Keenan;T Bauer;D Miller;N Altorki
Journal / Conference
Society of Thoracic Surgeons (STS) (Jan 27-29, 2024, San Antonio, TX)
Year
2024
Research Committee(s)
Lung

Phase II Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG/NCI Experience: Invasive Mucinous or Non-mucinous Lepidic Adenocarcinoma of the Lung (Formerly Bronchioloalveolar Carcinoma)

Authors
Y Chae;M Othus;S Patel;D Gerber;T Tanvetyanon;L Il-Young Chung;H Kim;C McLeod;G Lopez;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
Therapeutic Advances in Medical Oncology Nov 22:16:17588359241293401
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39583952
PMC
PMC11583498
Study Number(s)
S1609

Next-generation cytogenomics using proximity ligation technology on the AVITI genome sequencing platform

Authors
S Eacker;M Malig;K Langford;M Islam;A Muratov;B Nelson;O Sala-Torra;M Fang;S Sullivan;I Liachko;C Yeung;J Radich
Journal / Conference
Association for Molecular Pathology (November 14-18, 2024, Salt Lake City, UT), poster
Year
2024
Research Committee(s)
Leukemia
Study Number(s)
S0106

Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial

Authors
NL Henry;J Unger;A Darke;T Skaar;M Fisch;D Hershman
Journal / Conference
Contemporary Clinical Trials Dec:147:107712
Year
2024
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID39395534
PMC
PMC11620912
Study Number(s)
S2010